FDA, EMA, WHO all expect lifecycle thinking now.
ISPE calls missing this shift a business risk — not just a compliance gap.
→ validationms.com | Week 1 of 7 | #Validation40 #GMP #PharmaMfg #ISPE #Pharma
ISPE calls missing this shift a business risk — not just a compliance gap.
→ validationms.com | Week 1 of 7 | #Validation40 #GMP #PharmaMfg #ISPE #Pharma
April 16, 2026 at 4:04 PM
FDA, EMA, WHO all expect lifecycle thinking now.
ISPE calls missing this shift a business risk — not just a compliance gap.
→ validationms.com | Week 1 of 7 | #Validation40 #GMP #PharmaMfg #ISPE #Pharma
ISPE calls missing this shift a business risk — not just a compliance gap.
→ validationms.com | Week 1 of 7 | #Validation40 #GMP #PharmaMfg #ISPE #Pharma